These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29493051)

  • 1. Evaluation of a chronic kidney disease risk assessment service in community pharmacies.
    Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
    Nephrology (Carlton); 2019 Mar; 24(3):301-307. PubMed ID: 29493051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.
    Gheewala PA; Zaidi STR; Jose MD; Bereznicki L; Peterson GM; Castelino RL
    J Nephrol; 2018 Feb; 31(1):27-36. PubMed ID: 28181150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacist intervention in patients with renal impairment.
    Pourrat X; Sipert AS; Gatault P; Sautenet B; Hay N; Guinard F; Guegan F; Halimi JM
    Int J Clin Pharm; 2015 Dec; 37(6):1172-9. PubMed ID: 26385098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service.
    Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
    Prev Chronic Dis; 2018 Jun; 15():E81. PubMed ID: 29908050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of urine dipstick and albumin:creatinine ratio for chronic kidney disease screening: A population-based study.
    Park JI; Baek H; Kim BR; Jung HH
    PLoS One; 2017; 12(2):e0171106. PubMed ID: 28151999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
    BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis.
    Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ
    Nephrology (Carlton); 2019 Jun; 24(6):605-614. PubMed ID: 30039893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.
    Tesfaye W; Krass I; Sud K; Johnson DW; Van C; Versace VL; McMorrow R; Fethney J; Mullan J; Tran A; Robson B; Vagholkar S; Kairaitis L; Gisev N; Fathima M; Tong V; Coric N; Castelino RL
    BMJ Open; 2023 Dec; 13(12):e079110. PubMed ID: 38128937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study.
    van Mil D; Kieneker LM; Evers-Roeten B; Thelen MHM; de Vries H; Hemmelder MH; Dorgelo A; van Etten RW; Heerspink HJL; Gansevoort RT
    Lancet; 2023 Sep; 402(10407):1052-1064. PubMed ID: 37597522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies.
    Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
    Int J Clin Pharm; 2018 Apr; 40(2):458-463. PubMed ID: 29442280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for chronic kidney disease in Australia: a pilot study in the community and workplace.
    Mathew TH; Corso O; Ludlow M; Boyle A; Cass A; Chadban SJ; Joyner B; Shephard M; Usherwood T
    Kidney Int Suppl; 2010 Mar; (116):S9-16. PubMed ID: 20186177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Kidney Disease among Middle-Aged and Elderly Population: A cross-sectional screening in a Hospital Camp in Varanasi, India.
    Rai PK; Rai P; Bhat RG; Bedi S
    Saudi J Kidney Dis Transpl; 2019; 30(4):795-802. PubMed ID: 31464235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of kidney function and risk assessment in a nationwide laboratory database: the Brazilian CHECK-CKD study.
    Guedes M; Dias PT; Réa RR; Calice-Silva V; Lopes M; Brandão AA; Bauer AC; Senerchia AA; de Castro E Abreu Rocha PTM; Rosa BB; Teixeira CM; Pecoits-Filho R
    BMC Nephrol; 2024 Jun; 25(1):191. PubMed ID: 38831397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study.
    Fraser SD; Parkes J; Culliford D; Santer M; Roderick PJ
    BMC Fam Pract; 2015 Feb; 16():18. PubMed ID: 25879207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults.
    Kim YJ; Hwang SD; Oh TJ; Kim KM; Jang HC; Kimm H; Kim HC; Jee SH; Lim S
    Metab Syndr Relat Disord; 2017 Oct; 15(8):416-422. PubMed ID: 28832275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.
    Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; El-Dahiyat F
    Sci Rep; 2024 Mar; 14(1):7284. PubMed ID: 38538618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The See Kidney Disease Targeted Screening Program for CKD.
    Galbraith LE; Ronksley PE; Barnieh LJ; Kappel J; Manns BJ; Samuel SM; Jun M; Weaver R; Valk N; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):964-972. PubMed ID: 27197905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of chronic kidney disease: results of the PolNef study.
    Król E; Rutkowski B; Czarniak P; Kraszewska E; Lizakowski S; Szubert R; Czekalski S; Sułowicz W; Wiecek A
    Am J Nephrol; 2009; 29(3):264-73. PubMed ID: 18812692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.